Efficacy and safety of a once daily regimen with efavirenz, lamivudine, and didanosine, with and without food, as initial therapy for HIV Infection: the ELADI study.

Source:http://linkedlifedata.com/resource/pubmed/id/17961110

Download in:

View as

General Info

PMID
17961110